Zasocitinib
Zasocitinib (NDI-034858) is a TYK2 inhibitor, target TYK2 JH2 domain with binding constant Kd of [1].
Product Specifications
CAS Number
2272904-53-5
Product Name Alternative
NDI-034858; TAK-279
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zasocitinib.html
Purity
99.24
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CO[C@H](CC1)[C@@H]1NC(C2=C3N(N=C2)C(NC)=CC(NC4=CC=CN(C5=CC=CC=N5)C4=O)=N3)=O
Molecular Formula
C23H24N8O3
Molecular Weight
460.49
Precautions
H302, H315, H319
References & Citations
[1]Masse, Craig E, et al. Pyrazolopyrimidines as TYK2 inhibitors and their preparation: World Intellectual Property Organization, WO2019023468. 2019-01-31.|[2]Leit S, Greenwood J, Carriero S, et al. Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279. J Med Chem. 2023;66 (15) :10473-10496.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681384-100 1x 100 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1384), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY422918 100 µg
TCP1 eta (CCT7) (NM_001009570) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNUM1593-50 1x 50 µL
Aurora B (Proliferation Marker) (AURKB/1593), 1mg/mL
Sign In for Pricing
View Details